Prognosis was most strongly related to the presence of the Philadelphia chromosome (p=0.03) and age under 15 years (p=0.01). We conclude that patients with biphenotypic leukemia should have risk stratification with treatment tailored to their prognostic factors.
Andrei Gafita, Jérémie Calais, Hui Wang, Manuel Weber, Hendrik Rathke, Clemens Kratochwil, Rouzbeh Esfandiari, Wesley R. Armstrong, Shahneen Sandhu, Robert Tauber, Ebrahim S. Delpassand, Uwe Haberkorn, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber
Discussion(0)
No comments yet. Be the first to comment.